Ceesay Abraham

Charles River Laboratories International Inc ยท Director

Ceesay Abraham is listed in public filings as director. This Ceesay Abraham insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Charles River Laboratories International Inc (CRL), Rapport Therapeutics, Inc. Common Stock (RAPP), and Pacira BioSciences Inc (PCRX). Investors use Ceesay Abraham's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Charles River Laboratories International IncCRL$423k2.4k sharesGrant / ExerciseMay 8, 2026$255.4K1.4k shares$177.62--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$16M558.5k sharesSellFeb 18, 2026$103.2K3.6k shares$29.05--
Rapport Therapeutics, Inc. Common StockRAPP$663k22.8k sharesSellFeb 18, 2026$86.6K3k shares$29.04--
Rapport Therapeutics, Inc. Common StockRAPP$17M556.2k sharesSellFeb 18, 2026$68.0K2.3k shares$29.80--
Rapport Therapeutics, Inc. Common StockRAPP$618k20.7k sharesSellFeb 18, 2026$62.6K2.1k shares$29.80--
Rapport Therapeutics, Inc. Common StockRAPP$12M428k sharesGrant / ExerciseFeb 2, 2026$11.9M428k shares$27.75--
Rapport Therapeutics, Inc. Common StockRAPP$15M562.1k sharesSellJan 20, 2026$152.3K5.8k shares$26.12--
Rapport Therapeutics, Inc. Common StockRAPP$674k25.8k sharesSellJan 20, 2026$132.7K5.1k shares$26.11--
Rapport Therapeutics, Inc. Common StockRAPP$17M568.5k sharesSellDec 17, 2025$83.9K2.8k shares$30.04--
Rapport Therapeutics, Inc. Common StockRAPP$943k31.4k sharesSellDec 17, 2025$72.7K2.4k shares$30.04--
Rapport Therapeutics, Inc. Common StockRAPP$16M571.3k sharesSellDec 17, 2025$70.4K2.4k shares$28.84--
Rapport Therapeutics, Inc. Common StockRAPP$976k33.8k sharesSellDec 17, 2025$61.9K2.1k shares$28.84--
Rapport Therapeutics, Inc. Common StockRAPP$18M567.9k sharesSellDec 17, 2025$18.6K600 shares$31.04--
Rapport Therapeutics, Inc. Common StockRAPP$959k30.9k sharesSellDec 17, 2025$16.0K515 shares$31.04--
Rapport Therapeutics, Inc. Common StockRAPP$15M573.7k sharesSellNov 17, 2025$77.7K3.1k shares$25.43--
Rapport Therapeutics, Inc. Common StockRAPP$915k36k sharesSellNov 17, 2025$72.3K2.8k shares$25.44--
Rapport Therapeutics, Inc. Common StockRAPP$14M576.8k sharesSellNov 17, 2025$69.2K2.8k shares$24.92--
Rapport Therapeutics, Inc. Common StockRAPP$967k38.8k sharesSellNov 17, 2025$55.9K2.2k shares$24.91--
Rapport Therapeutics, Inc. Common StockRAPP$15M580.8k sharesSellOct 15, 2025$119.5K4.6k shares$25.72--
Rapport Therapeutics, Inc. Common StockRAPP$1.1M41.8k sharesSellOct 15, 2025$111.4K4.3k shares$25.75--
Rapport Therapeutics, Inc. Common StockRAPP$15M579.6k sharesSellOct 15, 2025$31.0K1.2k shares$26.14--
Rapport Therapeutics, Inc. Common StockRAPP$1.1M41.1k sharesSellOct 15, 2025$19.8K755 shares$26.17--
Rapport Therapeutics, Inc. Common StockRAPP$15M586.8k sharesSellSep 17, 2025$1.0M39.4k shares$26.30--
Rapport Therapeutics, Inc. Common StockRAPP$1.2M46.8k sharesSellSep 17, 2025$917.5K34.9k shares$26.30--
Rapport Therapeutics, Inc. Common StockRAPP$16M585.4k sharesSellSep 17, 2025$37.6K1.4k shares$26.87--
Rapport Therapeutics, Inc. Common StockRAPP$1.2M46.1k sharesSellSep 17, 2025$18.9K700 shares$27.04--
Pacira BioSciences IncPCRX$246k9k sharesSellSep 4, 2025$64.0K2.4k shares$27.19--
Pacira BioSciences IncPCRX$275k11.3k sharesGrant / ExerciseJun 11, 2025$274.5K11.3k shares$24.34--
Pacira BioSciences IncPCRX--11.4k sharesGrant / ExerciseJun 11, 2025Disclosure amount unavailable6.2k shares----
Charles River Laboratories International IncCRL$281k2.1k sharesGrant / ExerciseJun 2, 2025$281.2K2.1k shares$135.04--
Charles River Laboratories International IncCRL$128k946 sharesGrant / ExerciseJun 2, 2025$127.7K946 shares$135.04--
Rapport Therapeutics, Inc. Common StockRAPP$7.1M428k sharesGrant / ExerciseFeb 3, 2025$7.1M428k shares$16.60--
Pacira BioSciences IncPCRX$349k12.2k sharesGrant / ExerciseJun 12, 2024$349.3K12.2k shares$28.68--
Pacira BioSciences IncPCRX--5.2k sharesGrant / ExerciseJun 12, 2024Disclosure amount unavailable5.2k shares----